García M S, Barañao R I, Fernández O, Rumi L S
Acta Physiol Lat Am. 1983;33(1):15-20.
The suppressor activity induced by Concanavalin A (Con A) was evaluated in peripheral lymphocytes from 20 patients with solid malignant tumors of different origin, that is: 9 lung epidermoid carcinomas; 6 breast adenocarcinomas and 5 melanomas. Simultaneously 10 normal control subjects were studied. No significant differences in the percentage of suppression were found in patients bearing breast adenocarcinoma and lung epidermoid carcinoma as compared to normal subjects. Melanoma patients, on the contrary, showed significant differences on the same test. On the other hand, the Con A lymphoproliferative response was found to be only significantly increased in the melanoma patients compared to normal controls. No differences were found in the percentage of peripheral blood lymphocytes between patients and controls.
对来自20例不同起源实体恶性肿瘤患者(即9例肺表皮样癌、6例乳腺腺癌和5例黑色素瘤)的外周淋巴细胞中伴刀豆球蛋白A(Con A)诱导的抑制活性进行了评估。同时研究了10名正常对照受试者。与正常受试者相比,患乳腺腺癌和肺表皮样癌的患者在抑制百分比上未发现显著差异。相反,黑色素瘤患者在相同测试中表现出显著差异。另一方面,与正常对照相比,仅在黑色素瘤患者中发现Con A淋巴细胞增殖反应显著增加。患者和对照之间在外周血淋巴细胞百分比上未发现差异。